InsidersTradesSigma
Track the ST人福 share price and the full insider trade history of the company, a listed equity based in China. Shares are listed on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, ST人福 has published 20 reports. Market capitalisation: €29.2bn. The latest transaction was filed on 11 September 2024 (Sale). Among the most active insiders: 徐华斌. Every trade is free.
20
Insider Decl.
n/a
Thresholds
€554,715
1 ops.
Buy Volume
€23m
19 ops.
Sell Volume
11Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 6,080 of 28,958 companies
66.2
score / 100
Value71
Quality62
FCF yld6.1%
Earn yld6.4%
EV/EBITDA8.7x
ROE12%
Gross mgn48%
Net mgn7.7%
Debt/EBITDA2.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 11 September 2024
Declarations20 total
20 of 20 declarations
About ST人福
ST人福 is a company listed on the XSHG market, specializing in the healthcare and pharmaceutical sector. It focuses on the development and distribution of pharmaceutical products.